** Shares of Torrent Pharmaceuticals Ltd TORP.NS rise as
much as 2.7% to 3,184.75 rupees
** The pharma co says United States Food and Drug
Administration (USFDA) has issued establishment inspection
report with voluntary action indicated classification for
Pithampur manufacturing facility
** Adds that inspection has been successfully closed by the
FDA
** Stock on track to snap five weeks of losses
** Mean rating of 27 brokerages rating the stock is "buy";
their median PT is 3,589 rupees - LSEG data
** TORP stock has climbed 2.2% so far this week, adding to
YTD gains of 37.8%
(Reporting by Meenakshi Maidas in Bengaluru)
((meenakshi.maidas@thomsonreuters.com;))